Nordion Inc (NDZ) 11.43 $NDZ
Coverage of Health Care Sector Stocks -- Research on Agilent Technologies, Thermo Fisher Scientific, Nordion, and BG Medicine
PR Newswire - Tue Apr 15, 10:08AM CDT
On Monday, April 14, 2014, the NASDAQ Composite ended at 4,022.69, up 0.57%, the Dow Jones Industrial Average advanced 0.91% to 16,173.24, and the S&P 500 closed at 1,830.61, up 0.82%. The gains were broad based as all the 10 sectors ended the session in positive. The S&P 500 Health Care Sector Index finished the day at 648.05, up 0.51%, while the same has declined 3.97% in the last one month. Investor-Edge has initiated coverage on the following equities: Agilent Technologies Inc. (NYSE: A), Thermo Fisher Scientific Inc. (NYSE: TMO), Nordion Inc. (NYSE: NDZ) and BG Medicine Inc. (NASDAQ: BGMD). Free technical research on A, TMO, NDZ and BGMD can be downloaded upon signing up at:
Healthcare Companies Enter into Acquisitions and Partnerships, Receive FDA Approvals, Make Appointments, and Receive Recognitions - Analyst Notes on Nordion, Abbott, Covidien, DaVita, and Sirona
PR Newswire - Fri Apr 11, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Nordion Inc. (NYSE: NDZ), Abbott Laboratories (NYSE: ABT), Covidien plc (NYSE: COV), DaVita HealthCare Partners Inc. (NYSE: DVA), and Sirona Dental Systems Inc. (NASDAQ: SIRO). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Senior Notes Conversions, FDA Drug Approvals, Acquisitions, Stock Price Updates, and Clinical Trial Studies - Analyst Notes on Gilead, Pfizer, Nordion, Intuitive Surgical, and Novartis
PR Newswire - Thu Apr 03, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Gilead Sciences Inc. (NASDAQ: GILD), Pfizer Inc. (NYSE: PFE), Nordion Inc. (NYSE: NDZ), Intuitive Surgical, Inc. (NASDAQ: ISRG), and Novartis AG (NYSE: NVS). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
NYSE stocks posting largest volume increases
AP - Tue Apr 01, 5:03PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on New York Stock Exchange at the close of trading:
Nordion Obtains Court Order to Delay its Annual Meeting Date
Business Wire - Tue Apr 01, 2:00PM CDT
Nordion Inc. (TSX:NDN) (NYSE:NDZ), announced today that the Ontario Superior Court of Justice has granted an order extending the time for calling and holding the Company's annual general meeting (the "AGM"
, which was scheduled to take place on April 29, 2014. The order allows Nordion to combine its AGM with its shareholders' special meeting to consider the transaction announced on March 28, 2014 whereby Nordion entered into a definitive agreement (the "Arrangement Agreement" to be acquired by Sterigenics. The order further provides that the AGM has to be held no later than June 30, 2014.
Nordion Hits New Yearly High after Being Acquired by Sterigenics; Zynga to Release Financial Results April 23rd
ACCESSWIRE - Tue Apr 01, 12:51AM CDT
Nordion Inc. (NYSE: NDZ) - For an in-depth report on Nordion Inc. follow: www.BullTrends.com/stockquote/NDZ
NYSE stocks posting largest percentage increases
AP - Mon Mar 31, 6:04PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on New York Stock Exchange at the close of trading:
Most active New York Stock Exchange-traded stocks
AP - Mon Mar 31, 6:04PM CDT
NEW YORK (AP) — A look at New York Stock Exchange 10 most-active stocks at the close of trading:
Why Nordion (NDZ) Stock Hit a One-Year High Today (Update)
at The Street - Mon Mar 31, 3:15PM CDT
Nordion (NDZ) rose Monday after news that Sterigenics acquired the isotope supplier for $727 million. The deal is for $11.75 a share; Nordion closed at $11.53 on Monday. Nordion is one of the world's leading producers of molybdenum-99, an isotope...
Why Nordion, Inc. Shares Soared Today
Brian Pacampara, The Motley Fool - Motley Fool - Mon Mar 31, 12:16PM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Nordion, Inc. popped 11% today after...
Nordion Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Acquisition by Sterigenics
Business Wire - Mon Mar 31, 10:57AM CDT
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Nordion Inc. ("Nordion" (NYSE: NDZ) related to the acquisition by Sterigenics for shareholders. Under the terms of the definitive agreement valued at approximately $727 million, consideration will consist of $11.75 per share in cash, which is well below at least one analyst's estimated value of $13.00 per share.
IIROC Trade Resumption - Nordion Inc.
Newsfile Corp - Mon Mar 31, 7:05AM CDT
Trading resumes in:
Sterigenics Enters into Definitive Agreement to Acquire Nordion
Business Wire - Fri Mar 28, 3:56PM CDT
--Shareholders to receive an aggregate cash consideration of US $11.75 per share
IIROC Trade Halt - Nordion Inc.
Newsfile Corp - Fri Mar 28, 2:52PM CDT
The following issues have been halted by IIROC:
Hill-Rom Elects William G. Dempsey to its Board of Directors
PR Newswire - Mon Mar 10, 7:00AM CDT
Hill-Rom Holdings, Inc. (NYSE: HRC) announced today that William G. Dempsey has been elected to its Board of Directors. He currently serves as a director of Landauer, Inc., Nordion Inc., and Hospira, Inc., and previously held various executive positions with Abbott Laboratories, including Executive Vice President of Global Pharmaceuticals, Senior Vice President of Pharmaceutical Operations, and Senior Vice President of International Operations. He also previously served as Chairman of the International Section of the Pharmaceutical Research and Manufacturers of America (PhRMA) and as Chairman of the Accelerating Access Initiative, a cooperative public-private partnership of UNAIDS, the World Bank, and six research-based pharmaceutical companies.
Nordion jumps up to GAAP net income of USD35.3m in Q1 fiscal 2014
M2 - Mon Mar 10, 5:00AM CDT
Health service company Nordion (TSX:NDN.TO) (NYSE:NDZ) announced on Friday its GAAP net income of USD35.3m for the first quarter of fiscal 2014.
Nordion Reports First Quarter Fiscal 2014 Financial Results
Business Wire - Fri Mar 07, 6:00AM CST
--GAAP earnings per share (EPS) of $0.57 in Q1 2014 versus $nil in Q1 2013. Non-GAAP adjusted EPS of $0.59 in Q1 2014, up from non-GAAP adjusted EPS of $0.05 in Q1 2013
Coverage of Health Care Sector Stocks -- Research on Agilent Technologies, Thermo Fisher Scientific, Nordion, and BG Medicine
PR Newswire - Tue Apr 15, 10:08AM CDT
On Monday, April 14, 2014, the NASDAQ Composite ended at 4,022.69, up 0.57%, the Dow Jones Industrial Average advanced 0.91% to 16,173.24, and the S&P 500 closed at 1,830.61, up 0.82%. The gains were broad based as all the 10 sectors ended the session in positive. The S&P 500 Health Care Sector Index finished the day at 648.05, up 0.51%, while the same has declined 3.97% in the last one month. Investor-Edge has initiated coverage on the following equities: Agilent Technologies Inc. (NYSE: A), Thermo Fisher Scientific Inc. (NYSE: TMO), Nordion Inc. (NYSE: NDZ) and BG Medicine Inc. (NASDAQ: BGMD). Free technical research on A, TMO, NDZ and BGMD can be downloaded upon signing up at:
Healthcare Companies Enter into Acquisitions and Partnerships, Receive FDA Approvals, Make Appointments, and Receive Recognitions - Analyst Notes on Nordion, Abbott, Covidien, DaVita, and Sirona
PR Newswire - Fri Apr 11, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Nordion Inc. (NYSE: NDZ), Abbott Laboratories (NYSE: ABT), Covidien plc (NYSE: COV), DaVita HealthCare Partners Inc. (NYSE: DVA), and Sirona Dental Systems Inc. (NASDAQ: SIRO). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Senior Notes Conversions, FDA Drug Approvals, Acquisitions, Stock Price Updates, and Clinical Trial Studies - Analyst Notes on Gilead, Pfizer, Nordion, Intuitive Surgical, and Novartis
PR Newswire - Thu Apr 03, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Gilead Sciences Inc. (NASDAQ: GILD), Pfizer Inc. (NYSE: PFE), Nordion Inc. (NYSE: NDZ), Intuitive Surgical, Inc. (NASDAQ: ISRG), and Novartis AG (NYSE: NVS). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
NYSE stocks posting largest volume increases
AP - Tue Apr 01, 5:03PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on New York Stock Exchange at the close of trading:
Nordion Obtains Court Order to Delay its Annual Meeting Date
Business Wire - Tue Apr 01, 2:00PM CDT
Nordion Inc. (TSX:NDN) (NYSE:NDZ), announced today that the Ontario Superior Court of Justice has granted an order extending the time for calling and holding the Company's annual general meeting (the "AGM"
, which was scheduled to take place on April 29, 2014. The order allows Nordion to combine its AGM with its shareholders' special meeting to consider the transaction announced on March 28, 2014 whereby Nordion entered into a definitive agreement (the "Arrangement Agreement" to be acquired by Sterigenics. The order further provides that the AGM has to be held no later than June 30, 2014. Nordion Hits New Yearly High after Being Acquired by Sterigenics; Zynga to Release Financial Results April 23rd
ACCESSWIRE - Tue Apr 01, 12:51AM CDT
Nordion Inc. (NYSE: NDZ) - For an in-depth report on Nordion Inc. follow: www.BullTrends.com/stockquote/NDZ
NYSE stocks posting largest percentage increases
AP - Mon Mar 31, 6:04PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on New York Stock Exchange at the close of trading:
Most active New York Stock Exchange-traded stocks
AP - Mon Mar 31, 6:04PM CDT
NEW YORK (AP) — A look at New York Stock Exchange 10 most-active stocks at the close of trading:
Why Nordion (NDZ) Stock Hit a One-Year High Today (Update)
at The Street - Mon Mar 31, 3:15PM CDT
Nordion (NDZ) rose Monday after news that Sterigenics acquired the isotope supplier for $727 million. The deal is for $11.75 a share; Nordion closed at $11.53 on Monday. Nordion is one of the world's leading producers of molybdenum-99, an isotope...
Why Nordion, Inc. Shares Soared Today
Brian Pacampara, The Motley Fool - Motley Fool - Mon Mar 31, 12:16PM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Nordion, Inc. popped 11% today after...
Nordion Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Acquisition by Sterigenics
Business Wire - Mon Mar 31, 10:57AM CDT
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Nordion Inc. ("Nordion"
(NYSE: NDZ) related to the acquisition by Sterigenics for shareholders. Under the terms of the definitive agreement valued at approximately $727 million, consideration will consist of $11.75 per share in cash, which is well below at least one analyst's estimated value of $13.00 per share. IIROC Trade Resumption - Nordion Inc.
Newsfile Corp - Mon Mar 31, 7:05AM CDT
Trading resumes in:
Sterigenics Enters into Definitive Agreement to Acquire Nordion
Business Wire - Fri Mar 28, 3:56PM CDT
--Shareholders to receive an aggregate cash consideration of US $11.75 per share
IIROC Trade Halt - Nordion Inc.
Newsfile Corp - Fri Mar 28, 2:52PM CDT
The following issues have been halted by IIROC:
Hill-Rom Elects William G. Dempsey to its Board of Directors
PR Newswire - Mon Mar 10, 7:00AM CDT
Hill-Rom Holdings, Inc. (NYSE: HRC) announced today that William G. Dempsey has been elected to its Board of Directors. He currently serves as a director of Landauer, Inc., Nordion Inc., and Hospira, Inc., and previously held various executive positions with Abbott Laboratories, including Executive Vice President of Global Pharmaceuticals, Senior Vice President of Pharmaceutical Operations, and Senior Vice President of International Operations. He also previously served as Chairman of the International Section of the Pharmaceutical Research and Manufacturers of America (PhRMA) and as Chairman of the Accelerating Access Initiative, a cooperative public-private partnership of UNAIDS, the World Bank, and six research-based pharmaceutical companies.
Nordion jumps up to GAAP net income of USD35.3m in Q1 fiscal 2014
M2 - Mon Mar 10, 5:00AM CDT
Health service company Nordion (TSX:NDN.TO) (NYSE:NDZ) announced on Friday its GAAP net income of USD35.3m for the first quarter of fiscal 2014.
Nordion Reports First Quarter Fiscal 2014 Financial Results
Business Wire - Fri Mar 07, 6:00AM CST
--GAAP earnings per share (EPS) of $0.57 in Q1 2014 versus $nil in Q1 2013. Non-GAAP adjusted EPS of $0.59 in Q1 2014, up from non-GAAP adjusted EPS of $0.05 in Q1 2013
